Pancreastatin is a 49 amino acid peptide first isolated, purified and
characterized from porcine pancreas. Its biological activity in differ
ent tissues can be assigned to the C-terminal part of the molecule. Pa
ncreastatin has a prohormonal precursor, chromogranin A, which is a gl
ycoprotein present in neuroendocrine cells, including the endocrine pa
ncreas. We have been interested in pancreastatin action in the liver.
We found that pancreastatin has a glycogenolytic effect in the hepatoc
yte both in vivo and in vitro. We then studied and characterized the s
pecific pancreastatin receptor in the rat liver plasma membrane, as we
ll as the specific signal transduction. This receptor appears to be co
upled to two different G proteins. A pertussis toxin-insensitive G pro
teins leads to the activation of phospholipase C, and therefore mediat
es the glycogenolytic effect in the liver by increasing cytoplasmic fr
ee calcium and stimulating protein kinase C. The role of cyclic GMP in
the action of pancreastatin is not known yet, although it seems to re
gulate negatively the activation of phospholipase C. The precise mecha
nism by which pancreastatin stimulates guanylate cyclase activity rema
ins to be studied.